Report Details
Not found what are you looking for
Pharma & Healthcare
Global Psilocybin Assisted Therapy Market Research Report 2023(Status and Outlook)
By Type : NaturalSynthetic
By Application : Cluster HeadachesAnxiety DisordersPsychiatric Disorders
Description
ToC>
Tables & Figures
Companies
Speak with Analyst
Report Overview
Global Psilocybin Assisted Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of theGlobal Psilocybin Assisted Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Psilocybin Assisted Therapy market in any manner.
Global Psilocybin Assisted Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
MindMed
Compass Pathways
ATAI Life Sciences
Field Trip
DemeRx
Eleusis
Hikma Pharmaceuticals PLC
Pfizer
Verrian
Jazz Pharmaceuticals
Market Segmentation (by Type)
Natural
Synthetic
Market Segmentation (by Application)
Cluster Headaches
Anxiety Disorders
Psychiatric Disorders
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Psilocybin Assisted Therapy Market
• Overview of the regional outlook of the Psilocybin Assisted Therapy Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Psilocybin Assisted Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
FAQ
- You should buy this report from Xcellent Insights for a better clarity on market scenarios.
- The market report has been prepared using a pragmatic approach to suit your needs.
- We have an extensive library of reports that can help you understand the market landscape and make informed decisions about your business.
- Additionally, the reports are written by experienced analysts who have a deep understanding of the market and the latest trends.
- Besides, customization is a value-added service if you decide to opt.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Psilocybin Assisted Therapy
1.2 Key Market Segments
1.2.1 Psilocybin Assisted Therapy Segment by Type
1.2.2 Psilocybin Assisted Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Psilocybin Assisted Therapy Market Overview
2.1Global Market Overview
2.1.1Global Psilocybin Assisted Therapy Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2Global Psilocybin Assisted Therapy Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3Global Market Size by Region
3 Psilocybin Assisted Therapy Market Competitive Landscape
3.1Global Psilocybin Assisted Therapy Sales by Manufacturers (2018-2023)
3.2Global Psilocybin Assisted Therapy Revenue Market Share by Manufacturers (2018-2023)
3.3 Psilocybin Assisted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4Global Psilocybin Assisted Therapy Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Psilocybin Assisted Therapy Sales Sites, Area Served, Product Type
3.6 Psilocybin Assisted Therapy Market Competitive Situation and Trends
3.6.1 Psilocybin Assisted Therapy Market Concentration Rate
3.6.2Global 5 and 10 Largest Psilocybin Assisted Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Psilocybin Assisted Therapy Industry Chain Analysis
4.1 Psilocybin Assisted Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Psilocybin Assisted Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Psilocybin Assisted Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2Global Psilocybin Assisted Therapy Sales Market Share by Type (2018-2023)
6.3Global Psilocybin Assisted Therapy Market Size Market Share by Type (2018-2023)
6.4Global Psilocybin Assisted Therapy Price by Type (2018-2023)
7 Psilocybin Assisted Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2Global Psilocybin Assisted Therapy Market Sales by Application (2018-2023)
7.3Global Psilocybin Assisted Therapy Market Size (M USD) by Application (2018-2023)
7.4Global Psilocybin Assisted Therapy Sales Growth Rate by Application (2018-2023)
8 Psilocybin Assisted Therapy Market Segmentation by Region
8.1Global Psilocybin Assisted Therapy Sales by Region
8.1.1Global Psilocybin Assisted Therapy Sales by Region
8.1.2Global Psilocybin Assisted Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Psilocybin Assisted Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Psilocybin Assisted Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Psilocybin Assisted Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Psilocybin Assisted Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Psilocybin Assisted Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 MindMed
9.1.1 MindMed Psilocybin Assisted Therapy Basic Information
9.1.2 MindMed Psilocybin Assisted Therapy Product Overview
9.1.3 MindMed Psilocybin Assisted Therapy Product Market Performance
9.1.4 MindMed Business Overview
9.1.5 MindMed Psilocybin Assisted Therapy SWOT Analysis
9.1.6 MindMed Recent Developments
9.2 Compass Pathways
9.2.1 Compass Pathways Psilocybin Assisted Therapy Basic Information
9.2.2 Compass Pathways Psilocybin Assisted Therapy Product Overview
9.2.3 Compass Pathways Psilocybin Assisted Therapy Product Market Performance
9.2.4 Compass Pathways Business Overview
9.2.5 Compass Pathways Psilocybin Assisted Therapy SWOT Analysis
9.2.6 Compass Pathways Recent Developments
9.3 ATAI Life Sciences
9.3.1 ATAI Life Sciences Psilocybin Assisted Therapy Basic Information
9.3.2 ATAI Life Sciences Psilocybin Assisted Therapy Product Overview
9.3.3 ATAI Life Sciences Psilocybin Assisted Therapy Product Market Performance
9.3.4 ATAI Life Sciences Business Overview
9.3.5 ATAI Life Sciences Psilocybin Assisted Therapy SWOT Analysis
9.3.6 ATAI Life Sciences Recent Developments
9.4 Field Trip
9.4.1 Field Trip Psilocybin Assisted Therapy Basic Information
9.4.2 Field Trip Psilocybin Assisted Therapy Product Overview
9.4.3 Field Trip Psilocybin Assisted Therapy Product Market Performance
9.4.4 Field Trip Business Overview
9.4.5 Field Trip Psilocybin Assisted Therapy SWOT Analysis
9.4.6 Field Trip Recent Developments
9.5 DemeRx
9.5.1 DemeRx Psilocybin Assisted Therapy Basic Information
9.5.2 DemeRx Psilocybin Assisted Therapy Product Overview
9.5.3 DemeRx Psilocybin Assisted Therapy Product Market Performance
9.5.4 DemeRx Business Overview
9.5.5 DemeRx Psilocybin Assisted Therapy SWOT Analysis
9.5.6 DemeRx Recent Developments
9.6 Eleusis
9.6.1 Eleusis Psilocybin Assisted Therapy Basic Information
9.6.2 Eleusis Psilocybin Assisted Therapy Product Overview
9.6.3 Eleusis Psilocybin Assisted Therapy Product Market Performance
9.6.4 Eleusis Business Overview
9.6.5 Eleusis Recent Developments
9.7 Hikma Pharmaceuticals PLC
9.7.1 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Basic Information
9.7.2 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Overview
9.7.3 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Market Performance
9.7.4 Hikma Pharmaceuticals PLC Business Overview
9.7.5 Hikma Pharmaceuticals PLC Recent Developments
9.8 Pfizer
9.8.1 Pfizer Psilocybin Assisted Therapy Basic Information
9.8.2 Pfizer Psilocybin Assisted Therapy Product Overview
9.8.3 Pfizer Psilocybin Assisted Therapy Product Market Performance
9.8.4 Pfizer Business Overview
9.8.5 Pfizer Recent Developments
9.9 Verrian
9.9.1 Verrian Psilocybin Assisted Therapy Basic Information
9.9.2 Verrian Psilocybin Assisted Therapy Product Overview
9.9.3 Verrian Psilocybin Assisted Therapy Product Market Performance
9.9.4 Verrian Business Overview
9.9.5 Verrian Recent Developments
9.10 Jazz Pharmaceuticals
9.10.1 Jazz Pharmaceuticals Psilocybin Assisted Therapy Basic Information
9.10.2 Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Overview
9.10.3 Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Market Performance
9.10.4 Jazz Pharmaceuticals Business Overview
9.10.5 Jazz Pharmaceuticals Recent Developments
10 Psilocybin Assisted Therapy Market Forecast by Region
10.1Global Psilocybin Assisted Therapy Market Size Forecast
10.2Global Psilocybin Assisted Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Psilocybin Assisted Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Psilocybin Assisted Therapy Market Size Forecast by Region
10.2.4 South America Psilocybin Assisted Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Psilocybin Assisted Therapy by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1Global Psilocybin Assisted Therapy Market Forecast by Type (2024-2029)
11.1.1Global Forecasted Sales of Psilocybin Assisted Therapy by Type (2024-2029)
11.1.2Global Psilocybin Assisted Therapy Market Size Forecast by Type (2024-2029)
11.1.3Global Forecasted Price of Psilocybin Assisted Therapy by Type (2024-2029)
11.2Global Psilocybin Assisted Therapy Market Forecast by Application (2024-2029)
11.2.1Global Psilocybin Assisted Therapy Sales (K MT) Forecast by Application
11.2.2Global Psilocybin Assisted Therapy Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Psilocybin Assisted Therapy Market Size Comparison by Region (M USD)
Table 5.Global Psilocybin Assisted Therapy Sales (K MT) by Manufacturers (2018-2023)
Table 6.Global Psilocybin Assisted Therapy Sales Market Share by Manufacturers (2018-2023)
Table 7.Global Psilocybin Assisted Therapy Revenue (M USD) by Manufacturers (2018-2023)
Table 8.Global Psilocybin Assisted Therapy Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psilocybin Assisted Therapy as of 2022)
Table 10.Global Market Psilocybin Assisted Therapy Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Psilocybin Assisted Therapy Sales Sites and Area Served
Table 12. Manufacturers Psilocybin Assisted Therapy Product Type
Table 13.Global Psilocybin Assisted Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Psilocybin Assisted Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Psilocybin Assisted Therapy Market Challenges
Table 22. Market Restraints
Table 23.Global Psilocybin Assisted Therapy Sales by Type (K MT)
Table 24.Global Psilocybin Assisted Therapy Market Size by Type (M USD)
Table 25.Global Psilocybin Assisted Therapy Sales (K MT) by Type (2018-2023)
Table 26.Global Psilocybin Assisted Therapy Sales Market Share by Type (2018-2023)
Table 27.Global Psilocybin Assisted Therapy Market Size (M USD) by Type (2018-2023)
Table 28.Global Psilocybin Assisted Therapy Market Size Share by Type (2018-2023)
Table 29.Global Psilocybin Assisted Therapy Price (USD/MT) by Type (2018-2023)
Table 30.Global Psilocybin Assisted Therapy Sales (K MT) by Application
Table 31.Global Psilocybin Assisted Therapy Market Size by Application
Table 32.Global Psilocybin Assisted Therapy Sales by Application (2018-2023) & (K MT)
Table 33.Global Psilocybin Assisted Therapy Sales Market Share by Application (2018-2023)
Table 34.Global Psilocybin Assisted Therapy Sales by Application (2018-2023) & (M USD)
Table 35.Global Psilocybin Assisted Therapy Market Share by Application (2018-2023)
Table 36.Global Psilocybin Assisted Therapy Sales Growth Rate by Application (2018-2023)
Table 37.Global Psilocybin Assisted Therapy Sales by Region (2018-2023) & (K MT)
Table 38.Global Psilocybin Assisted Therapy Sales Market Share by Region (2018-2023)
Table 39. North America Psilocybin Assisted Therapy Sales by Country (2018-2023) & (K MT)
Table 40. Europe Psilocybin Assisted Therapy Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific Psilocybin Assisted Therapy Sales by Region (2018-2023) & (K MT)
Table 42. South America Psilocybin Assisted Therapy Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa Psilocybin Assisted Therapy Sales by Region (2018-2023) & (K MT)
Table 44. MindMed Psilocybin Assisted Therapy Basic Information
Table 45. MindMed Psilocybin Assisted Therapy Product Overview
Table 46. MindMed Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. MindMed Business Overview
Table 48. MindMed Psilocybin Assisted Therapy SWOT Analysis
Table 49. MindMed Recent Developments
Table 50. Compass Pathways Psilocybin Assisted Therapy Basic Information
Table 51. Compass Pathways Psilocybin Assisted Therapy Product Overview
Table 52. Compass Pathways Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. Compass Pathways Business Overview
Table 54. Compass Pathways Psilocybin Assisted Therapy SWOT Analysis
Table 55. Compass Pathways Recent Developments
Table 56. ATAI Life Sciences Psilocybin Assisted Therapy Basic Information
Table 57. ATAI Life Sciences Psilocybin Assisted Therapy Product Overview
Table 58. ATAI Life Sciences Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. ATAI Life Sciences Business Overview
Table 60. ATAI Life Sciences Psilocybin Assisted Therapy SWOT Analysis
Table 61. ATAI Life Sciences Recent Developments
Table 62. Field Trip Psilocybin Assisted Therapy Basic Information
Table 63. Field Trip Psilocybin Assisted Therapy Product Overview
Table 64. Field Trip Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. Field Trip Business Overview
Table 66. Field Trip Psilocybin Assisted Therapy SWOT Analysis
Table 67. Field Trip Recent Developments
Table 68. DemeRx Psilocybin Assisted Therapy Basic Information
Table 69. DemeRx Psilocybin Assisted Therapy Product Overview
Table 70. DemeRx Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. DemeRx Business Overview
Table 72. DemeRx Psilocybin Assisted Therapy SWOT Analysis
Table 73. DemeRx Recent Developments
Table 74. Eleusis Psilocybin Assisted Therapy Basic Information
Table 75. Eleusis Psilocybin Assisted Therapy Product Overview
Table 76. Eleusis Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. Eleusis Business Overview
Table 78. Eleusis Recent Developments
Table 79. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Basic Information
Table 80. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Overview
Table 81. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Hikma Pharmaceuticals PLC Business Overview
Table 83. Hikma Pharmaceuticals PLC Recent Developments
Table 84. Pfizer Psilocybin Assisted Therapy Basic Information
Table 85. Pfizer Psilocybin Assisted Therapy Product Overview
Table 86. Pfizer Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Pfizer Business Overview
Table 88. Pfizer Recent Developments
Table 89. Verrian Psilocybin Assisted Therapy Basic Information
Table 90. Verrian Psilocybin Assisted Therapy Product Overview
Table 91. Verrian Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Verrian Business Overview
Table 93. Verrian Recent Developments
Table 94. Jazz Pharmaceuticals Psilocybin Assisted Therapy Basic Information
Table 95. Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Overview
Table 96. Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Jazz Pharmaceuticals Business Overview
Table 98. Jazz Pharmaceuticals Recent Developments
Table 99.Global Psilocybin Assisted Therapy Sales Forecast by Region (2024-2029) & (K MT)
Table 100.Global Psilocybin Assisted Therapy Market Size Forecast by Region (2024-2029) & (M USD)
Table 101. North America Psilocybin Assisted Therapy Sales Forecast by Country (2024-2029) & (K MT)
Table 102. North America Psilocybin Assisted Therapy Market Size Forecast by Country (2024-2029) & (M USD)
Table 103. Europe Psilocybin Assisted Therapy Sales Forecast by Country (2024-2029) & (K MT)
Table 104. Europe Psilocybin Assisted Therapy Market Size Forecast by Country (2024-2029) & (M USD)
Table 105. Asia Pacific Psilocybin Assisted Therapy Sales Forecast by Region (2024-2029) & (K MT)
Table 106. Asia Pacific Psilocybin Assisted Therapy Market Size Forecast by Region (2024-2029) & (M USD)
Table 107. South America Psilocybin Assisted Therapy Sales Forecast by Country (2024-2029) & (K MT)
Table 108. South America Psilocybin Assisted Therapy Market Size Forecast by Country (2024-2029) & (M USD)
Table 109. Middle East and Africa Psilocybin Assisted Therapy Consumption Forecast by Country (2024-2029) & (Units)
Table 110. Middle East and Africa Psilocybin Assisted Therapy Market Size Forecast by Country (2024-2029) & (M USD)
Table 111.Global Psilocybin Assisted Therapy Sales Forecast by Type (2024-2029) & (K MT)
Table 112.Global Psilocybin Assisted Therapy Market Size Forecast by Type (2024-2029) & (M USD)
Table 113.Global Psilocybin Assisted Therapy Price Forecast by Type (2024-2029) & (USD/MT)
Table 114.Global Psilocybin Assisted Therapy Sales (K MT) Forecast by Application (2024-2029)
Table 115.Global Psilocybin Assisted Therapy Market Size Forecast by Application (2024-2029) & (M USD)
List of Figures
Figure 1. Product Picture of Psilocybin Assisted Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4.Global Psilocybin Assisted Therapy Market Size (M USD), 2018-2029
Figure 5.Global Psilocybin Assisted Therapy Market Size (M USD) (2018-2029)
Figure 6.Global Psilocybin Assisted Therapy Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Psilocybin Assisted Therapy Market Size by Country (M USD)
Figure 11. Psilocybin Assisted Therapy Sales Share by Manufacturers in 2022
Figure 12.Global Psilocybin Assisted Therapy Revenue Share by Manufacturers in 2022
Figure 13. Psilocybin Assisted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14.Global Market Psilocybin Assisted Therapy Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. TheGlobal 5 and 10 Largest Players: Market Share by Psilocybin Assisted Therapy Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17.Global Psilocybin Assisted Therapy Market Share by Type
Figure 18. Sales Market Share of Psilocybin Assisted Therapy by Type (2018-2023)
Figure 19. Sales Market Share of Psilocybin Assisted Therapy by Type in 2022
Figure 20. Market Size Share of Psilocybin Assisted Therapy by Type (2018-2023)
Figure 21. Market Size Market Share of Psilocybin Assisted Therapy by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23.Global Psilocybin Assisted Therapy Market Share by Application
Figure 24.Global Psilocybin Assisted Therapy Sales Market Share by Application (2018-2023)
Figure 25.Global Psilocybin Assisted Therapy Sales Market Share by Application in 2022
Figure 26.Global Psilocybin Assisted Therapy Market Share by Application (2018-2023)
Figure 27.Global Psilocybin Assisted Therapy Market Share by Application in 2022
Figure 28.Global Psilocybin Assisted Therapy Sales Growth Rate by Application (2018-2023)
Figure 29.Global Psilocybin Assisted Therapy Sales Market Share by Region (2018-2023)
Figure 30. North America Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America Psilocybin Assisted Therapy Sales Market Share by Country in 2022
Figure 32. U.S. Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada Psilocybin Assisted Therapy Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico Psilocybin Assisted Therapy Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe Psilocybin Assisted Therapy Sales Market Share by Country in 2022
Figure 37. Germany Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific Psilocybin Assisted Therapy Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Psilocybin Assisted Therapy Sales Market Share by Region in 2022
Figure 44. China Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America Psilocybin Assisted Therapy Sales and Growth Rate (K MT)
Figure 50. South America Psilocybin Assisted Therapy Sales Market Share by Country in 2022
Figure 51. Brazil Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa Psilocybin Assisted Therapy Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Psilocybin Assisted Therapy Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa Psilocybin Assisted Therapy Sales and Growth Rate (2018-2023) & (K MT)
Figure 61.Global Psilocybin Assisted Therapy Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62.Global Psilocybin Assisted Therapy Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63.Global Psilocybin Assisted Therapy Sales Market Share Forecast by Type (2024-2029)
Figure 64.Global Psilocybin Assisted Therapy Market Share Forecast by Type (2024-2029)
Figure 65.Global Psilocybin Assisted Therapy Sales Forecast by Application (2024-2029)
Figure 66.Global Psilocybin Assisted Therapy Market Share Forecast by Application (2024-2029)
MindMed
Compass Pathways
ATAI Life Sciences
Field Trip
DemeRx
Eleusis
Hikma Pharmaceuticals PLC
Pfizer
Verrian
Jazz Pharmaceuticals
Why Choose Us
- Extensive Library of Reports.
- Identify the clients' needs.
- Pragmatic Research Approach.
- Clarity on Market Scenarios.
- Tailor-Made Solutions.
- Expert Analysts Team.
- Competitive and Fair Prices.
Clientele
Thank you
Xcellent Insights has received your query!